Wang M, Mequanint K
Biomimetics (Basel). 2024; 9(11).
PMID: 39590248
PMC: 11592370.
DOI: 10.3390/biomimetics9110676.
Wang Y, Fu Y, Wang Q, Kong D, Wang Z, Liu J
Mater Today Bio. 2024; 28:101194.
PMID: 39221196
PMC: 11364905.
DOI: 10.1016/j.mtbio.2024.101194.
Snyder Y, Mann F, Middleton J, Murashita T, Carney J, Bianco R
Appl Mater Today. 2024; 39.
PMID: 39131741
PMC: 11308761.
DOI: 10.1016/j.apmt.2024.102323.
Xu C, Yang K, Xu Y, Meng X, Zhou Y, Xu Y
J Nanobiotechnology. 2024; 22(1):378.
PMID: 38943185
PMC: 11212200.
DOI: 10.1186/s12951-024-02656-5.
Besseling P, Szymczyk W, Teraa M, Toorop R, Wu D, Driessen R
Adv Healthc Mater. 2024; 13(17):e2303888.
PMID: 38451476
PMC: 11469054.
DOI: 10.1002/adhm.202303888.
Self-organizing behaviors of cardiovascular cells on synthetic nanofiber scaffolds.
Peters M, Brister J, Tang E, Zhang F, Lucian V, Trackey P
APL Bioeng. 2023; 7(4):046114.
PMID: 38046543
PMC: 10693444.
DOI: 10.1063/5.0172423.
Strategies for Development of Synthetic Heart Valve Tissue Engineering Scaffolds.
Snyder Y, Jana S
Prog Mater Sci. 2023; 139.
PMID: 37981978
PMC: 10655624.
DOI: 10.1016/j.pmatsci.2023.101173.
Evaluation of pliable bioresorbable, elastomeric aortic valve prostheses in sheep during 12 months post implantation.
Vis A, de Kort B, Szymczyk W, van Rijswijk J, Dekker S, Driessen R
Commun Biol. 2023; 6(1):1166.
PMID: 37964029
PMC: 10646052.
DOI: 10.1038/s42003-023-05533-3.
Remote Outcomes with Poly-ε-Caprolactone Aortic Grafts in Rats.
Dokuchaeva A, Mochalova A, Timchenko T, Kuznetsova E, Podolskaya K, Pashkovskaya O
Polymers (Basel). 2023; 15(21).
PMID: 37959984
PMC: 10649699.
DOI: 10.3390/polym15214304.
Influence of Polymer Stiffness and Geometric Design on Fluid Mechanics in Tissue-Engineered Pulmonary Valve Scaffolds.
Pedersen D, Kim S, DAmore A, Wagner W
Ann Biomed Eng. 2023; 52(3):575-587.
PMID: 37935910
DOI: 10.1007/s10439-023-03401-z.
Bio-Inspired Fiber Reinforcement for Aortic Valves: Scaffold Production Process and Characterization.
Boehm C, Donay C, Lubig A, Ruetten S, Sesa M, Fernandez-Colino A
Bioengineering (Basel). 2023; 10(9).
PMID: 37760166
PMC: 10525898.
DOI: 10.3390/bioengineering10091064.
Multiscale structure and function of the aortic valve apparatus.
El-Nashar H, Sabry M, Tseng Y, Francis N, Latif N, Parker K
Physiol Rev. 2023; 104(4):1487-1532.
PMID: 37732828
PMC: 11495199.
DOI: 10.1152/physrev.00038.2022.
Pediatric pulmonary valve replacements: Clinical challenges and emerging technologies.
Crago M, Winlaw D, Farajikhah S, Dehghani F, Naficy S
Bioeng Transl Med. 2023; 8(4):e10501.
PMID: 37476058
PMC: 10354783.
DOI: 10.1002/btm2.10501.
Calcification in Pulmonary Heart Valve Tissue Engineering: A Systematic Review and Meta-Analysis of Large-Animal Studies.
van der Valk D, Fomina A, Uiterwijk M, Hooijmans C, Akiva A, Kluin J
JACC Basic Transl Sci. 2023; 8(5):572-591.
PMID: 37325410
PMC: 10264707.
DOI: 10.1016/j.jacbts.2022.09.009.
In vivo efficacy of a polymer layered decellularized matrix composite as a cell honing cardiovascular tissue substitute.
Mudigonda J, Onohara D, Amedi A, Suresh K, Kono T, Corporan D
Mater Today Bio. 2022; 17:100451.
PMID: 36444341
PMC: 9700326.
DOI: 10.1016/j.mtbio.2022.100451.
Macrophage-extracellular matrix interactions: Perspectives for tissue engineered heart valve remodeling.
Poulis N, Martin M, Hoerstrup S, Emmert M, Fioretta E
Front Cardiovasc Med. 2022; 9:952178.
PMID: 36176991
PMC: 9513146.
DOI: 10.3389/fcvm.2022.952178.
Anisotropicity and flexibility in trilayered microfibrous substrates promote heart valve leaflet tissue engineering.
Snyder Y, Jana S
Biomed Mater. 2022; 17(6).
PMID: 36150373
PMC: 9629372.
DOI: 10.1088/1748-605X/ac94ae.
Biofabrication of Sodium Alginate Hydrogel Scaffolds for Heart Valve Tissue Engineering.
Rioux Y, Fradette J, Maciel Y, Begin-Drolet A, Ruel J
Int J Mol Sci. 2022; 23(15).
PMID: 35955704
PMC: 9368972.
DOI: 10.3390/ijms23158567.
Marker-Independent Monitoring of and Degradation of Supramolecular Polymers Applied in Cardiovascular Tissue Engineering.
Marzi J, Munnig Schmidt E, Brauchle E, Wissing T, Bauer H, Serrero A
Front Cardiovasc Med. 2022; 9:885873.
PMID: 35656396
PMC: 9152121.
DOI: 10.3389/fcvm.2022.885873.
Engineering Efforts to Refine Compatibility and Duration of Aortic Valve Replacements: An Overview of Previous Expectations and New Promises.
Rizzi S, Ragazzini S, Pesce M
Front Cardiovasc Med. 2022; 9:863136.
PMID: 35509271
PMC: 9058060.
DOI: 10.3389/fcvm.2022.863136.